Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546598 · ClinicalTrials.gov registry record · Phase 4
Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System
A Phase 4 study, sponsored by DePuy Orthopaedics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 106
- Enrollment target
NCT00546598: Clinical Trial Phase 4 study, sponsored by DePuy Orthopaedics.
NCT00546598 is a Phase 4 study that was terminated before completion, run by DePuy Orthopaedics. The registered enrollment target is 106 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00546598, a Phase 4 study, was terminated before completion, sponsored by DePuy Orthopaedics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 106 participants
- Enrollment target
Study Summary
This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.
Interventions
- DEVICE Total hip replacement/arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-01-01 |
| Est. Completion | 2014-04-01 |
| Phase | Phase 4 |
Why NCT00546598 stopped before completion
NCT00546598 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Total hip replacement/arthroplasty is the first listed.
NCT00546598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00546598 about?
NCT00546598 is a clinical study titled "Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System". This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.
What is the current status of trial NCT00546598?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 106 participants. The study started on 2006-01-01. Estimated completion is 2014-04-01.
What interventions are being tested in trial NCT00546598?
The interventions under investigation include: Total hip replacement/arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT00546598?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00546598's enrollment target sits among peer trials
106 747th of 2000 higher than 1,252 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI